New Atopic Dermatitis (ECZEMA) Research Study - Now Open!
You may be eligible to participate in study recruiting volunteers for an upcoming PAID (up to $1,000) Eczema Research Study.
No health insurance is required to participate.
QUALIFIED PARTICIPANTS MAY RECEIVE:
Compensation up to $1,000 available for time and travel.
You will receive all study-related care from a physician at no cost
TO QUALIFY, PARTICIPANTS MUST:
Be ages 18 - 63.
Have been diagnosed with moderate to severe Atopic Dermatitis (Eczema) for at least 3 year.
Must be willing to participate for 32 weeks including 7 visits to the clinic.
Have had previous treatment for Atopic Dermatitis (Eczema) or current treatment using JAK inhibitor oral pills (examples include: ruxolitinib (Jakafi), baricitinib (Olumiant), peficitinib (Smyraf), abrocitinib (Cibinqo), filgotinib (Jyseleca), fedratinib (Inrebic), and deucravacitinib (Sotyktu)).
Contact our Research Staff Today - (Call Monday-Friday 8am-5pm)
️ 877-620-7787 ext. 120 ️
Se Habla Español
If you reply via CL mail relay,
Please Include the Following Information;
Your Name (First & Last):
Best Contact Phone#(s):
Best Time To Contact You:
Trial/Study you are interested in:
You can also apply Online anytime at: https://study.rocketclinical.com/sd-eczema-6/
